Latest On Intercept Pharmaceuticals, Inc (ICPT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-30 01:08 EST | News | Drug pricing watchdog raises alarm over upcoming liver disease meds | N/A |  |
| 2023-05-22 22:57 EST | News | Intercept Pharmaceuticals: Do Not Expect PBC Sales To Save The Company | N/A | |
| 2023-05-22 22:57 EST | News | Intercept crashes 29% after FDA AdCom snub for liver disease therapy | N/A | |
| 2023-05-20 14:34 EST | News | Intercept Faces Setback On NASH Approval: Unpacking The ADCOM Decision And Its Implications | N/A | |
| 2023-05-20 01:24 EST | News | Intercept fails to win FDA panel backing for NASH drug (updated) | N/A | |
| 2023-05-19 11:07 EST | News | Intercept stock trading halted ahead of FDA panel meeting for liver disease drug | N/A | |
| 2023-05-17 18:23 EST | News | Intercept slips 26% as FDA comments on NASH therapy ahead of AdCom meeting | N/A | |
| 2023-05-17 18:23 EST | News | Hot Stocks: AMZN rises on new ECHO launch; ICPT falls on FDA comment; WAL leads the regional bank rally; EVGO down on equity raise; TSLA gains | N/A | |
| 2023-05-17 18:23 EST | News | Intercept downgraded at RayJay citing potential FDA snub for Ocaliva in NASH | N/A | |
| 2023-05-17 04:26 EST | News | Intercept receives Orphan Drug status for rare autoimmune disease candidate | N/A | |
| 2023-04-27 19:36 EST | News | Intercept Pharma GAAP EPS of -$0.77 misses by $0.15, revenue of $68M misses by $4.68M | N/A | |
| 2023-04-27 19:36 EST | News | Intercept Pharma off 11% on Q1 misses | N/A | |
| 2023-04-27 19:36 EST | News | Intercept Pharmaceuticals, Inc. (ICPT) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-26 18:43 EST | News | Intercept Pharma Q1 2023 Earnings Preview | N/A | |
| 2023-04-25 18:25 EST | News | Navigating The NASH Storm: Intercept Pharmaceuticals' Uncertain Voyage | N/A | |
| 2023-04-12 18:25 EST | News | Intercept Pharmaceuticals: Will OCA Win Approval For NASH In June? | N/A | |
| 2023-03-11 00:27 EST | News | Intercept to face FDA AdCom meeting on NASH candidate in May | N/A | |
| 2023-03-02 17:44 EST | News | Intercept Pharma GAAP EPS of -$0.50 misses by $0.26, revenue of $77.22M misses by $0.86M | N/A | |
| 2023-03-02 17:44 EST | News | Intercept Pharmaceuticals, Inc. (ICPT) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-02 03:02 EST | News | Intercept Pharma Q4 2022 Earnings Preview | N/A | |
| 2023-02-24 18:44 EST | News | Intercept Pharma settles with Apotex, MSN over Ocaliva patents (update) | N/A | |
| 2023-01-25 17:56 EST | News | Intercept Pharma gains after patent settlement with Amneal | N/A | |
| 2023-01-24 16:17 EST | News | Intercept: Huge Potential Upsides With Binary Catalyst Unlocking | N/A | |
| 2023-01-20 18:52 EST | News | Intercept: FDA Accepts Application For Ocaliva In NASH | N/A | |
| 2023-01-19 19:42 EST | News | Intercept gains as NASH candidate goes under FDA review | N/A | |
| 2023-01-11 11:10 EST | News | Intercept sees $343M adj. net sales in 2022 | N/A | |
| 2022-12-23 09:19 EST | News | Intercept resubmits application to FDA for OCA to treat liver disease | N/A | |
| 2022-11-07 20:14 EST | News | Intercept updates Phase 3 data for the NASH candidate | N/A | |
| 2022-11-04 21:17 EST | News | Intercept Pharmaceuticals' Q3 Call Points To Progress In Revenues, Pipeline | N/A | |
| 2022-11-04 03:57 EST | News | Intercept Pharmaceuticals: Trying Times | N/A | |
| 2022-11-02 02:49 EST | News | Intercept Pharma rises 12% on strong Q3 sales of Ocaliva therapy | N/A | |
| 2022-11-02 02:49 EST | News | Intercept Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-02 02:49 EST | News | Intercept Pharmaceuticals, Inc. (ICPT) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 10:49 EST | News | Intercept PharmaEPS of -$3.04, revenue of $77.59M | N/A | |
| 2022-09-30 18:37 EST | News | Intercept stock slumps 18% as liver disease drug fails phase 3 trial | N/A | |
| 2022-09-30 18:37 EST | News | Hot Stocks: ICPT drops on clinical data; LASE falls after IPO; AOUT, CRL rise | N/A | |
| 2022-09-22 02:32 EST | News | Intercept Pharma strengthens financial position through significant debt reduction | N/A | |
| 2022-09-20 17:48 EST | News | Intercept touts Ocaliva benefit in transplant-free survival in liver disease type | N/A | |
| 2022-09-02 17:23 EST | News | Intercept cuts debt further with deal to exchange convertible notes | N/A | |
| 2022-08-20 03:02 EST | News | Intercept reduces debt with repurchases of $327.9M convertible notes | N/A | |
| 2022-08-17 19:39 EST | News | Intercept, Dr. Reddy’s settle patent dispute over Oclaiva generics | N/A | |
| 2022-08-13 13:01 EST | News | Intercept Pharmaceuticals: Too Risky To Buy At This Stage | N/A | |
| 2022-08-03 21:56 EST | News | Intercept Pharma GAAP EPS of -$0.68, revenue of $71.76M | N/A | |
| 2022-08-03 21:55 EST | News | Intercept Pharmaceuticals, Inc. (ICPT) CEO Jerry Durso on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-03 21:55 EST | News | Intercept Pharma up 13% following Q2 revenue increase, NASH NDA resubmission | N/A | |
| 2022-08-02 16:45 EST | News | Intercept Pharma Q2 2022 Earnings Preview | N/A | |
| 2022-07-07 14:08 EST | News | Intercept to resubmit for FDA approval of NASH candidate after new analysis | N/A | |
| 2022-06-06 22:03 EST | News | Intercept announces delay for key FDA meeting ahead of filing for NASH candidate | N/A | |
| 2022-06-04 02:39 EST | News | Intercept shares mixed results for Ocaliva to support post-marketing requirements | N/A | |
| 2022-05-23 22:00 EST | News | Intercept: Increase Of Ocaliva Sales And A Few Catalysts | N/A | |
About Intercept Pharmaceuticals, Inc (ICPT):
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and other product candidates in various stages of clinical and preclinical development. It has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors. Intercept Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in New York, New York.
General
- Name Intercept Pharmaceuticals, Inc
- Symbol ICPT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 498
- Fiscal Year EndDecember
- IPO Date2012-10-11
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.interceptpharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 2.46
- Price/Book (Most Recent Quarter) 44.19
- Enterprise Value Revenue 2.8
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$5.31
- Next Year EPS Estimate -$5.51
- Next Quarter EPS Estimate -$1.56
- Profit Margin -88%
- Operating Margin -69%
- Return on Assets -20%
- Return on Equity -143255%
- Revenue 312.69 million
- Earnings Per Share -$10.44
- Revenue Per Share $9.48
- Gross Profit 307.37 million
- Quarterly Earnings Growth 16.5%
View More
Highlights
- Market Capitalization 760.61 million
- EBITDA -281096992
- PE Ratio 2.08
- PEG Ratio -0.69
- Analyst Target Price $41.59
- Book Value Per Share $1.57
View More
Share Statistics
- Shares Outstanding 33.02 million
- Shares Float 28.16 million
- % Held by Insiders 1570%
- % Held by Institutions 88.73%
- Shares Short 6.41 million
- Shares Short Prior Month 6.03 million
- Short Ratio 6.28
- Short % of Float 31%
- Short % of Shares Outstanding 19%
View More
Technicals
- Beta 1.61
- 52 Week High $95.98
- 52 Week Low $18.15
- 50 Day Moving Average 28.44
- 200 Day Moving Average 33.13
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Intercept Pharmaceuticals, Inc (ICPT) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Intercept Pharmaceuticals, Inc (ICPT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $83.27 million | -$1.58 | -$1.59 | 0.57% |
| 2020-09-30 | 2020-11-09 | $79.52 million | -$1.61 | -$1.94 | 17.15% |
| 2020-06-30 | 2020-08-10 | $N/A | -$1.92 | -$2.81 | 31.77% |
| 2020-03-31 | 2020-05-11 | $72.65 million | -$2.86 | -$2.87 | 0.47% |
| 2019-12-31 | 2020-02-25 | $71.5 million | -$2.99 | -$2.59 | -15.58% |
| 2019-09-30 | 2019-11-05 | $61.95 million | -$2.59 | -$2.34 | -10.76% |
| 2019-06-30 | 2019-08-07 | $66.3 million | -$2.28 | -$2.61 | 12.71% |
| 2019-03-31 | 2019-05-08 | $52.25 million | -$3.03 | -$2.58 | -17.38% |
| 2018-12-31 | 2019-02-28 | $53.28 million | -$2.97 | -$2.49 | -19.22% |
| 2018-09-30 | 2018-10-31 | $46.99 million | -$2.18 | -$2.65 | 17.74% |
| 2018-06-30 | 2018-08-02 | $43.58 million | -$2.58 | -$2.96 | 12.69% |
| 2018-03-31 | 2018-05-08 | $35.96 million | -$3.22 | -$3.37 | 4.57% |
| 2017-12-31 | 2018-02-14 | $37.69 million | -$4.43 | -$3.73 | -18.93% |
| 2017-09-30 | 2017-11-01 | $41.33 million | -$2.89 | -$3.40 | 14.93% |
| 2017-06-30 | 2017-07-31 | $30.89 million | -$3.46 | -$3.60 | 3.81% |
| 2017-03-31 | 2017-05-04 | $21.05 million | -$3.61 | -$4.17 | 13.34% |
| 2016-12-31 | 2017-02-23 | $13.81 million | -$4.84 | -$3.69 | -31.01% |
| 2016-09-30 | 2016-11-03 | $5.18 million | -$3.59 | -$3.64 | 1.4% |
| 2016-06-30 | 2016-08-04 | $5.52 million | -$3.14 | -$3.67 | 14.45% |
| 2016-03-31 | 2016-05-05 | $445000 | -$5.17 | -$3.76 | -37.47% |
| 2015-12-31 | 2016-02-23 | $446000 | -$3.62 | -$3.07 | -17.88% |
| 2015-09-30 | 2015-11-09 | $445000 | -$2.10 | -$2.74 | 23.36% |
| 2015-06-30 | 2015-08-05 | $446000 | -$1.99 | -$1.96 | -1.53% |
| 2015-03-31 | 2015-05-11 | $1.45 million | -$1.78 | -$1.69 | -5.33% |
| 2014-12-31 | 2015-03-02 | $446000 | -$1.63 | -$1.67 | 2.4% |
| 2014-09-30 | 2014-11-06 | $445000 | -$1.69 | -$1.10 | -53.64% |
| 2014-06-30 | 2014-08-11 | $446000 | $1.51 | -$0.12 | 1358.33% |
| 2014-03-31 | 2014-05-07 | $405000 | -$1.59 | -$0.72 | -120.83% |
| 2013-12-31 | 2014-03-14 | $406000 | -$0.64 | -$0.70 | 8.57% |
| 2013-09-30 | 2013-11-14 | $405000 | -$1.65 | -$0.51 | -223.53% |
| 2013-06-30 | 2013-08-13 | $406000 | -$0.79 | -$0.51 | -54.9% |
| 2013-03-31 | 2013-05-14 | $405000 | -$0.62 | -$0.44 | -40.91% |
| 2012-12-31 | 2013-03-18 | $406000 | -$2.02 | -$0.34 | -494.12% |
| 2012-09-30 | 2012-11-26 | $522000 | -$1.86 | -$0.87 | -113.79% |
Intercept Pharmaceuticals, Inc (ICPT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Intercept Pharmaceuticals, Inc (ICPT) Chart:
Intercept Pharmaceuticals, Inc (ICPT) News:
Below you will find a list of latest news for Intercept Pharmaceuticals, Inc (ICPT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Intercept Pharmaceuticals, Inc (ICPT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-16 | 2.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0 | CALL | 0 | 0 | 137.63 | FALSE | 0 | 0 |
| 2026-01-16 | 7.5 | 0 | CALL | 0 | 0 | 92.17 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 7.7 | CALL | 0 | 1 | 65.46 | FALSE | 0 | 0 |
| 2026-01-16 | 12.5 | 0 | CALL | 0 | 0 | 46.42 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 4.1 | CALL | 0 | 76 | 20.09 | FALSE | 0 | 0 |
| 2026-01-16 | 17.5 | 1.6 | CALL | 0 | 23 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 0.05 | CALL | 0 | 2617 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 22.5 | 0.15 | CALL | 0 | 16 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 0.05 | PUT | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 0.5 | PUT | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 0.05 | PUT | 0 | 272 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 17.5 | 0.05 | PUT | 0 | 1627 | 7.34 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 1.05 | PUT | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 0 | PUT | 0 | 0 | 18.39 | TRUE | 0 | 0 |
Latest ICPT Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 285 | $11.97 |
| Jun 13, 2022 7:59 PM EST | 37 | $11.97 |
| Jun 13, 2022 7:59 PM EST | 8 | $11.97 |
| Jun 13, 2022 7:59 PM EST | 5 | $11.97 |
| Jun 13, 2022 7:59 PM EST | 100 | $11.97 |
Intercept Pharmaceuticals, Inc (ICPT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920077691/0001104659-20-077691-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1270073/000031506620001015/0000315066-20-001015-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1270073/000083423720008724/0000834237-20-008724-index.htm |
| 2019-07-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1270073/000089720419000026/0000897204-19-000026-index.htm |
| 2019-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919047003/0001104659-19-047003-index.htm |
| 2019-08-23 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919047186/0001104659-19-047186-index.htm |
| 2019-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919048230/0001104659-19-048230-index.htm |
| 2019-10-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919056609/0001104659-19-056609-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465919056967/0001104659-19-056967-index.htm |
| 2019-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919058533/0001104659-19-058533-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465919059812/0001104659-19-059812-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919062781/0001104659-19-062781-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919064410/0001104659-19-064410-index.htm |
| 2019-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919064831/0001104659-19-064831-index.htm |
| 2019-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919064832/0001104659-19-064832-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919065554/0001104659-19-065554-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919065555/0001104659-19-065555-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919067741/0001104659-19-067741-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068397/0001104659-19-068397-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068398/0001104659-19-068398-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919069103/0001104659-19-069103-index.htm |
| 2019-12-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919070280/0001104659-19-070280-index.htm |
| 2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919070281/0001104659-19-070281-index.htm |
| 2019-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919073503/0001104659-19-073503-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919075193/0001104659-19-075193-index.htm |
| 2019-12-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076862/0001104659-19-076862-index.htm |
| 2019-12-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076863/0001104659-19-076863-index.htm |
| 2019-12-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076864/0001104659-19-076864-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001084/0001104659-20-001084-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001085/0001104659-20-001085-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001086/0001104659-20-001086-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001087/0001104659-20-001087-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001088/0001104659-20-001088-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001089/0001104659-20-001089-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001090/0001104659-20-001090-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001091/0001104659-20-001091-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001092/0001104659-20-001092-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001093/0001104659-20-001093-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920002350/0001104659-20-002350-index.htm |
| 2020-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920004918/0001104659-20-004918-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007260/0001104659-20-007260-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007261/0001104659-20-007261-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007262/0001104659-20-007262-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007263/0001104659-20-007263-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007264/0001104659-20-007264-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007265/0001104659-20-007265-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007266/0001104659-20-007266-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007267/0001104659-20-007267-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007268/0001104659-20-007268-index.htm |
| 2020-01-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007269/0001104659-20-007269-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920016893/0001104659-20-016893-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1270073/000110465920018594/0001104659-20-018594-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920022117/0001104659-20-022117-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920022118/0001104659-20-022118-index.htm |
| 2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920024006/0001104659-20-024006-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920024371/0001104659-20-024371-index.htm |
| 2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920024462/0001104659-20-024462-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920027330/0001104659-20-027330-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920034881/0001104659-20-034881-index.htm |
| 2020-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920038560/0001104659-20-038560-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043282/0001104659-20-043282-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043283/0001104659-20-043283-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043285/0001104659-20-043285-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043286/0001104659-20-043286-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043287/0001104659-20-043287-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043288/0001104659-20-043288-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043289/0001104659-20-043289-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920043290/0001104659-20-043290-index.htm |
| 2020-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920045621/0001104659-20-045621-index.htm |
| 2020-04-15 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1270073/000110465920046996/0001104659-20-046996-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1270073/000110465920053354/0001104659-20-053354-index.htm |
| 2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920053658/0001104659-20-053658-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920059097/0001104659-20-059097-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920060294/0001104659-20-060294-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920061768/0001104659-20-061768-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920061771/0001104659-20-061771-index.htm |
| 2020-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920065116/0001104659-20-065116-index.htm |
| 2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920066534/0001104659-20-066534-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920067902/0001104659-20-067902-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068477/0001104659-20-068477-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068529/0001104659-20-068529-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068530/0001104659-20-068530-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068531/0001104659-20-068531-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068533/0001104659-20-068533-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068534/0001104659-20-068534-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068535/0001104659-20-068535-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068536/0001104659-20-068536-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068537/0001104659-20-068537-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068539/0001104659-20-068539-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920074272/0001104659-20-074272-index.htm |
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920077691/0001104659-20-077691-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081430/0001104659-20-081430-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081432/0001104659-20-081432-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081433/0001104659-20-081433-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081435/0001104659-20-081435-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081438/0001104659-20-081438-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081440/0001104659-20-081440-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081441/0001104659-20-081441-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920081442/0001104659-20-081442-index.htm |
| 2020-07-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920083785/0001104659-20-083785-index.htm |
| 2020-07-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920084548/0001104659-20-084548-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920092382/0001104659-20-092382-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920093397/0001104659-20-093397-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920095692/0001104659-20-095692-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920095693/0001104659-20-095693-index.htm |
| 2020-08-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1270073/000110465920096170/0001104659-20-096170-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920097335/0001104659-20-097335-index.htm |
| 2020-08-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920098460/0001104659-20-098460-index.htm |
| 2020-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920100946/0001104659-20-100946-index.htm |
| 2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000110465920101204/0001104659-20-101204-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920106199/0001104659-20-106199-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920112316/0001104659-20-112316-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920112317/0001104659-20-112317-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920112318/0001104659-20-112318-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920112319/0001104659-20-112319-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920112320/0001104659-20-112320-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920112321/0001104659-20-112321-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000110465920112322/0001104659-20-112322-index.htm |
| 2020-05-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1270073/000114036120011794/0001140361-20-011794-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018617/0001140361-20-018617-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018619/0001140361-20-018619-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018621/0001140361-20-018621-index.htm |
| 2020-08-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1270073/000114036120019442/0001140361-20-019442-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1270073/000114420419011650/0001144204-19-011650-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419011719/0001144204-19-011719-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419011720/0001144204-19-011720-index.htm |
| 2019-03-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419017102/0001144204-19-017102-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018074/0001144204-19-018074-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018075/0001144204-19-018075-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018076/0001144204-19-018076-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018077/0001144204-19-018077-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018078/0001144204-19-018078-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018079/0001144204-19-018079-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018080/0001144204-19-018080-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018081/0001144204-19-018081-index.htm |
| 2019-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419019948/0001144204-19-019948-index.htm |
| 2019-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419019949/0001144204-19-019949-index.htm |
| 2019-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000114420419020097/0001144204-19-020097-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419020605/0001144204-19-020605-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419022020/0001144204-19-022020-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1270073/000114420419022368/0001144204-19-022368-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419023712/0001144204-19-023712-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000114420419024375/0001144204-19-024375-index.htm |
| 2019-05-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1270073/000114420419024546/0001144204-19-024546-index.htm |
| 2019-05-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1270073/000114420419024548/0001144204-19-024548-index.htm |
| 2019-05-10 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1270073/000114420419025075/0001144204-19-025075-index.htm |
| 2019-05-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1270073/000114420419025352/0001144204-19-025352-index.htm |
| 2019-05-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1270073/000114420419025355/0001144204-19-025355-index.htm |
| 2019-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419025390/0001144204-19-025390-index.htm |
| 2019-05-13 | 305B2 | Filing [Trust Indenture Act] | https://www.sec.gov/Archives/edgar/data/1270073/000114420419025423/0001144204-19-025423-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000114420419026054/0001144204-19-026054-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419026103/0001144204-19-026103-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419026104/0001144204-19-026104-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419026105/0001144204-19-026105-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419026106/0001144204-19-026106-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419027782/0001144204-19-027782-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419028491/0001144204-19-028491-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419028696/0001144204-19-028696-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031952/0001144204-19-031952-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031953/0001144204-19-031953-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031954/0001144204-19-031954-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031955/0001144204-19-031955-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031956/0001144204-19-031956-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031957/0001144204-19-031957-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031958/0001144204-19-031958-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031959/0001144204-19-031959-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031960/0001144204-19-031960-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000114420419032303/0001144204-19-032303-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033810/0001144204-19-033810-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033811/0001144204-19-033811-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033812/0001144204-19-033812-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033813/0001144204-19-033813-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033814/0001144204-19-033814-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033815/0001144204-19-033815-index.htm |
| 2019-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033816/0001144204-19-033816-index.htm |
| 2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419034749/0001144204-19-034749-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000114420419038032/0001144204-19-038032-index.htm |
| 2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419038975/0001144204-19-038975-index.htm |
| 2019-08-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1270073/000114420419039590/0001144204-19-039590-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419040154/0001144204-19-040154-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419040155/0001144204-19-040155-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419041878/0001144204-19-041878-index.htm |
| 2019-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419042624/0001144204-19-042624-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419045112/0001144204-19-045112-index.htm |
| 2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1270073/000114420419046315/0001144204-19-046315-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419047218/0001144204-19-047218-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419047219/0001144204-19-047219-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419047220/0001144204-19-047220-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419047222/0001144204-19-047222-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419047223/0001144204-19-047223-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419047224/0001144204-19-047224-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000114420419047225/0001144204-19-047225-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1270073/000155837019004442/0001558370-19-004442-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1270073/000155837019007747/0001558370-19-007747-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1270073/000155837019009997/0001558370-19-009997-index.htm |
| 2020-02-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1270073/000155837020001314/0001558370-20-001314-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1270073/000155837020006235/0001558370-20-006235-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1270073/000155837020010181/0001558370-20-010181-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000155951520000001/0001559515-20-000001-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000155951520000002/0001559515-20-000002-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1270073/000156922220000001/0001569222-20-000001-index.htm |
Intercept Pharmaceuticals, Inc (ICPT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intercept Pharmaceuticals, Inc (ICPT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1570%Institutional Ownership: 8873%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-01-23 | Jason Campagna | Chief Medical Officer | Buy | 4,200.00 | 10,503.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007262/0001104659-20-007262-index.htm | ||
| 2019-01-03 | David A Ford | Chief Human Resources Officer | Sell | 259.00 | 117.16 | 30,344.44 | 10,580.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001085/0001104659-20-001085-index.htm |
| 2020-05-28 | Luca Benatti | Director | Buy | 1,595.00 | 10,721.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068537/0001104659-20-068537-index.htm | ||
| 2019-03-29 | Paolo Fundaro | Director | Sell | 2,171.00 | 107.45 | 233,272.21 | 11,114.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419017102/0001144204-19-017102-index.htm |
| 2019-10-23 | David A Ford | Chief Human Resources Officer | Sell | 58.00 | 70.00 | 4,060.00 | 11,396.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919056609/0001104659-19-056609-index.htm |
| 2019-09-16 | David A Ford | Chief Human Resources Officer | Sell | 800.00 | 70.00 | 56,000.00 | 11,546.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419045112/0001144204-19-045112-index.htm |
| 2020-04-09 | David A Ford | Chief Human Resources Officer | Sell | 58.00 | 70.00 | 4,060.00 | 13,882.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920045621/0001104659-20-045621-index.htm |
| 2019-12-27 | Christian Weyer | EVP, Research & Development | Sell | 1,581.00 | 123.24 | 194,842.44 | 14,178.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076864/0001104659-19-076864-index.htm |
| 2020-01-23 | David A Ford | Chief Human Resources Officer | Buy | 3,600.00 | 14,180.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007265/0001104659-20-007265-index.htm | ||
| 2019-05-20 | Paolo Fundaro | Director | Buy | 3,461.00 | 9.30 | 32,195.26 | 14,575.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419027782/0001144204-19-027782-index.htm |
| 2019-11-27 | Christian Weyer | EVP, Research & Development | Sell | 1,040.00 | 101.65 | 105,716.00 | 15,646.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919069103/0001104659-19-069103-index.htm |
| 2019-12-27 | Christian Weyer | EVP, Research & Development | Buy | 416.00 | 59.12 | 24,593.92 | 15,705.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076864/0001104659-19-076864-index.htm |
| 2019-12-27 | Christian Weyer | EVP, Research & Development | Buy | 54.00 | 58.74 | 3,171.96 | 15,759.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076864/0001104659-19-076864-index.htm |
| 2019-11-19 | Christian Weyer | EVP, Research & Development | Sell | 1,550.00 | 85.00 | 131,750.00 | 15,759.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919065555/0001104659-19-065555-index.htm |
| 2019-11-25 | Christian Weyer | EVP, Research & Development | Sell | 1,855.00 | 100.00 | 185,500.00 | 15,759.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068398/0001104659-19-068398-index.htm |
| 2019-11-26 | Christian Weyer | EVP, Research & Development | Sell | 4,373.00 | 100.00 | 437,300.00 | 15,759.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068398/0001104659-19-068398-index.htm |
| 2019-11-27 | Christian Weyer | EVP, Research & Development | Buy | 875.00 | 59.12 | 51,730.00 | 16,634.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919069103/0001104659-19-069103-index.htm |
| 2019-11-27 | Christian Weyer | EVP, Research & Development | Buy | 52.00 | 58.74 | 3,054.48 | 16,686.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919069103/0001104659-19-069103-index.htm |
| 2020-04-27 | Christian Weyer | EVP, Research & Development | Sell | 181.00 | 85.95 | 15,556.95 | 17,140.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920053658/0001104659-20-053658-index.htm |
| 2019-11-13 | Christian Weyer | EVP, Research & Development | Sell | 946.00 | 85.00 | 80,410.00 | 17,309.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919064831/0001104659-19-064831-index.htm |
| 2020-02-27 | Christian Weyer | EVP, Research & Development | Sell | 113.00 | 87.62 | 9,901.06 | 17,367.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920027330/0001104659-20-027330-index.htm |
| 2019-11-25 | Christian Weyer | EVP, Research & Development | Buy | 1,750.00 | 59.12 | 103,460.00 | 17,509.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068398/0001104659-19-068398-index.htm |
| 2019-11-25 | Christian Weyer | EVP, Research & Development | Buy | 105.00 | 58.74 | 6,167.70 | 17,614.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068398/0001104659-19-068398-index.htm |
| 2020-01-27 | Christian Weyer | EVP, Research & Development | Sell | 723.00 | 94.04 | 67,990.92 | 17,837.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007260/0001104659-20-007260-index.htm |
| 2019-05-20 | Paolo Fundaro | Director | Buy | 3,288.00 | 21.50 | 70,692.00 | 17,863.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419027782/0001144204-19-027782-index.htm |
| 2020-01-23 | Christian Weyer | EVP, Research & Development | Buy | 4,800.00 | 18,560.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007260/0001104659-20-007260-index.htm | ||
| 2019-12-03 | Gail Cawkwell | SVP, Med Affairs, Safety & PV | Buy | 80.00 | 54.63 | 4,370.40 | 18,722.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919070281/0001104659-19-070281-index.htm |
| 2019-12-26 | Gail Cawkwell | SVP, Med Affairs, Safety & PV | Sell | 54.00 | 125.00 | 6,750.00 | 18,722.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076862/0001104659-19-076862-index.htm |
| 2019-12-31 | Gail Cawkwell | SVP, Med Affairs, Safety & PV | Sell | 262.00 | 125.00 | 32,750.00 | 18,722.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001084/0001104659-20-001084-index.htm |
| 2019-10-29 | Lisa Bright | President, International | Sell | 595.00 | 75.00 | 44,625.00 | 18,732.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919058533/0001104659-19-058533-index.htm |
| 2019-12-26 | Gail Cawkwell | SVP, Med Affairs, Safety & PV | Buy | 54.00 | 54.63 | 2,950.02 | 18,776.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076862/0001104659-19-076862-index.htm |
| 2019-04-25 | SRINIVAS AKKARAJU | Director | Buy | 2,499.00 | 21.50 | 53,728.50 | 18,955.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419022020/0001144204-19-022020-index.htm |
| 2019-12-31 | Gail Cawkwell | SVP, Med Affairs, Safety & PV | Buy | 262.00 | 54.63 | 14,313.06 | 18,984.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001084/0001104659-20-001084-index.htm |
| 2019-03-01 | Christian Weyer | EVP, Research & Development | Sell | 333.00 | 103.16 | 34,352.28 | 19,107.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419011720/0001144204-19-011720-index.htm |
| 2019-06-20 | Paolo Fundaro | Director | Buy | 1,570.00 | 19,433.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031956/0001144204-19-031956-index.htm | ||
| 2019-04-18 | Gail Cawkwell | SVP, Med Affairs, Safety & PV | Buy | 1,750.00 | 54.63 | 95,602.50 | 19,599.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419020605/0001144204-19-020605-index.htm |
| 2019-07-03 | Lisa Bright | President, International | Sell | 595.00 | 78.66 | 46,802.70 | 19,857.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419033813/0001144204-19-033813-index.htm |
| 2019-04-25 | SRINIVAS AKKARAJU | Director | Buy | 1,001.00 | 31.90 | 31,931.90 | 19,956.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419022020/0001144204-19-022020-index.htm |
| 2019-11-26 | Christian Weyer | EVP, Research & Development | Buy | 4,267.00 | 59.12 | 252,265.04 | 20,026.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068398/0001104659-19-068398-index.htm |
| 2019-11-26 | Christian Weyer | EVP, Research & Development | Buy | 106.00 | 58.74 | 6,226.44 | 20,132.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068398/0001104659-19-068398-index.htm |
| 2019-04-03 | Lisa Bright | President, International | Sell | 594.00 | 115.01 | 68,315.94 | 20,982.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018076/0001144204-19-018076-index.htm |
| 2020-05-28 | Paolo Fundaro | Director | Buy | 1,595.00 | 21,028.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068529/0001104659-20-068529-index.htm | ||
| 2020-01-23 | Richard J Kim | President US Comm & Strat Mktg | Buy | 5,400.00 | 21,498.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007267/0001104659-20-007267-index.htm | ||
| 2019-06-20 | SRINIVAS AKKARAJU | Director | Buy | 1,570.00 | 21,526.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031953/0001144204-19-031953-index.htm | ||
| 2019-11-19 | Ryan T Sullivan | General Counsel and Secretary | Sell | 3,829.00 | 85.00 | 325,465.00 | 21,889.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919065554/0001104659-19-065554-index.htm |
| 2020-01-23 | Gail Cawkwell | SVP, Med Affairs, Safety & PV | Buy | 4,200.00 | 22,573.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007263/0001104659-20-007263-index.htm | ||
| 2020-01-23 | Lisa Bright | President, International | Buy | 4,800.00 | 22,614.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007261/0001104659-20-007261-index.htm | ||
| 2020-05-28 | SRINIVAS AKKARAJU | Director | Buy | 1,595.00 | 23,121.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068539/0001104659-20-068539-index.htm | ||
| 2019-11-19 | Ryan T Sullivan | General Counsel and Secretary | Sell | 8,325.00 | 85.00 | 707,625.00 | 25,718.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919065554/0001104659-19-065554-index.htm |
| 2019-11-13 | Ryan T Sullivan | General Counsel and Secretary | Sell | 500.00 | 85.00 | 42,500.00 | 26,429.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919064832/0001104659-19-064832-index.htm |
| 2020-01-23 | Ryan T Sullivan | General Counsel and Secretary | Buy | 5,600.00 | 26,680.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007269/0001104659-20-007269-index.htm | ||
| 2019-11-13 | Ryan T Sullivan | General Counsel and Secretary | Buy | 500.00 | 53.41 | 26,705.00 | 26,929.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919064832/0001104659-19-064832-index.htm |
| 2020-01-23 | Sandip Kapadia | CFO and Treasurer | Buy | 5,600.00 | 30,447.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007266/0001104659-20-007266-index.htm | ||
| 2019-05-14 | SRINIVAS AKKARAJU | Director | Buy | 119,760.00 | 83.50 | 9,999,960.00 | 330,697.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419026106/0001144204-19-026106-index.htm |
| 2019-11-19 | Ryan T Sullivan | General Counsel and Secretary | Buy | 8,325.00 | 53.41 | 444,638.25 | 34,043.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919065554/0001104659-19-065554-index.htm |
| 2019-08-20 | SRINIVAS AKKARAJU | Director | Buy | 37,604.00 | 65.85 | 2,476,223.40 | 368,301.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919047003/0001104659-19-047003-index.htm |
| 2019-04-03 | David Shapiro | Chief Medical Officer | Sell | 562.00 | 115.01 | 64,635.62 | 39,499.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419018081/0001144204-19-018081-index.htm |
| 2019-04-15 | David Shapiro | Chief Medical Officer | Sell | 2,000.00 | 95.00 | 190,000.00 | 39,499.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419019949/0001144204-19-019949-index.htm |
| 2019-05-01 | David Shapiro | Chief Medical Officer | Sell | 2,000.00 | 86.28 | 172,560.00 | 39,499.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419023712/0001144204-19-023712-index.htm |
| 2019-08-21 | SRINIVAS AKKARAJU | Director | Buy | 29,000.00 | 67.12 | 1,946,480.00 | 397,301.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919047003/0001104659-19-047003-index.htm |
| 2019-08-22 | SRINIVAS AKKARAJU | Director | Buy | 1,180.00 | 64.30 | 75,874.00 | 398,481.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919047003/0001104659-19-047003-index.htm |
| 2020-08-17 | Francesco Micheli | 10% Share Holder | Sell | 1,235,512.00 | 46.75 | 57,760,186.00 | 4,000,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018619/0001140361-20-018619-index.htm |
| 2020-08-17 | Paolo Fundaro | Director | Sell | 1,235,512.00 | 46.75 | 57,760,186.00 | 4,000,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018617/0001140361-20-018617-index.htm |
| 2020-08-17 | S.p.A. Genextra | 10% Share Holder | Sell | 1,235,512.00 | 46.75 | 57,760,186.00 | 4,000,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018621/0001140361-20-018621-index.htm |
| 2019-08-28 | SRINIVAS AKKARAJU | Director | Buy | 5,207.00 | 60.32 | 314,086.24 | 403,688.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919048230/0001104659-19-048230-index.htm |
| 2019-03-01 | David Shapiro | Chief Medical Officer | Sell | 2,000.00 | 103.16 | 206,320.00 | 40,543.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419011719/0001144204-19-011719-index.htm |
| 2020-01-23 | Jerome Benedict Durso | Chief Operating Officer | Buy | 10,600.00 | 40,927.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007264/0001104659-20-007264-index.htm | ||
| 2019-04-15 | David Shapiro | Chief Medical Officer | Buy | 2,000.00 | 31.90 | 63,800.00 | 41,499.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419019949/0001144204-19-019949-index.htm |
| 2019-05-01 | David Shapiro | Chief Medical Officer | Buy | 2,000.00 | 31.90 | 63,800.00 | 41,499.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419023712/0001144204-19-023712-index.htm |
| 2019-03-01 | David Shapiro | Chief Medical Officer | Buy | 2,000.00 | 31.90 | 63,800.00 | 42,543.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419011719/0001144204-19-011719-index.htm |
| 2019-11-25 | Mark Pruzanski | President & CEO | Sell | 14,563.00 | 100.00 | 1,456,300.00 | 469,126.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068397/0001104659-19-068397-index.htm |
| 2019-11-26 | Mark Pruzanski | President & CEO | Sell | 35,437.00 | 100.00 | 3,543,700.00 | 469,126.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068397/0001104659-19-068397-index.htm |
| 2019-12-26 | Mark Pruzanski | President & CEO | Sell | 417.00 | 125.00 | 52,125.00 | 469,126.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076863/0001104659-19-076863-index.htm |
| 2019-12-31 | Mark Pruzanski | President & CEO | Sell | 100.00 | 125.00 | 12,500.00 | 469,126.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001086/0001104659-20-001086-index.htm |
| 2019-11-25 | Mark Pruzanski | President & CEO | Buy | 39.00 | 8.67 | 338.00 | 469,165.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068397/0001104659-19-068397-index.htm |
| 2019-12-31 | Mark Pruzanski | President & CEO | Buy | 100.00 | 21.50 | 2,150.00 | 469,226.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920001086/0001104659-20-001086-index.htm |
| 2019-12-26 | Mark Pruzanski | President & CEO | Buy | 417.00 | 21.50 | 8,965.50 | 469,543.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919076863/0001104659-19-076863-index.htm |
| 2020-01-23 | Mark Pruzanski | President & CEO | Buy | 10,800.00 | 477,629.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920007268/0001104659-20-007268-index.htm | ||
| 2019-11-25 | Mark Pruzanski | President & CEO | Buy | 14,524.00 | 8.67 | 125,875.15 | 483,689.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068397/0001104659-19-068397-index.htm |
| 2019-11-26 | Mark Pruzanski | President & CEO | Buy | 19,880.00 | 8.67 | 172,294.00 | 489,006.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068397/0001104659-19-068397-index.htm |
| 2019-11-26 | Mark Pruzanski | President & CEO | Buy | 15,557.00 | 21.50 | 334,475.50 | 504,563.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919068397/0001104659-19-068397-index.htm |
| 2020-08-17 | Francesco Micheli | 10% Share Holder | Sell | 126,888.00 | 50.15 | 6,362,912.96 | 5,235,512.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018619/0001140361-20-018619-index.htm |
| 2020-08-17 | Paolo Fundaro | Director | Sell | 126,888.00 | 50.15 | 6,362,912.96 | 5,235,512.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018617/0001140361-20-018617-index.htm |
| 2020-08-17 | S.p.A. Genextra | 10% Share Holder | Sell | 126,888.00 | 50.15 | 6,362,912.96 | 5,235,512.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018621/0001140361-20-018621-index.htm |
| 2020-08-14 | Francesco Micheli | 10% Share Holder | Sell | 54,600.00 | 50.55 | 2,760,111.90 | 5,362,400.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018619/0001140361-20-018619-index.htm |
| 2020-08-14 | Paolo Fundaro | Director | Sell | 54,600.00 | 50.55 | 2,760,111.90 | 5,362,400.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018617/0001140361-20-018617-index.htm |
| 2020-08-14 | S.p.A. Genextra | 10% Share Holder | Sell | 54,600.00 | 50.55 | 2,760,111.90 | 5,362,400.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018621/0001140361-20-018621-index.htm |
| 2020-08-13 | Francesco Micheli | 10% Share Holder | Sell | 83,000.00 | 52.60 | 4,365,451.40 | 5,417,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018619/0001140361-20-018619-index.htm |
| 2020-08-13 | Paolo Fundaro | Director | Sell | 83,000.00 | 52.60 | 4,365,451.40 | 5,417,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018617/0001140361-20-018617-index.htm |
| 2020-08-13 | S.p.A. Genextra | 10% Share Holder | Sell | 83,000.00 | 52.60 | 4,365,451.40 | 5,417,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114036120018621/0001140361-20-018621-index.htm |
| 2020-05-13 | Francesco Micheli | 10% Share Holder | Sell | 595,578.00 | 84.60 | 50,385,898.80 | 5,500,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000156922220000001/0001569222-20-000001-index.htm |
| 2020-05-13 | Paolo Fundaro | Director | Sell | 595,578.00 | 84.60 | 50,385,898.80 | 5,500,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000155951520000002/0001559515-20-000002-index.htm |
| 2020-05-13 | S.p.A. Genextra | 10% Share Holder | Sell | 595,578.00 | 84.60 | 50,385,898.80 | 5,500,000.00 | https://www.sec.gov/Archives/edgar/data/1270073/000155951520000001/0001559515-20-000001-index.htm |
| 2019-06-20 | Nancy Miller-Rich | Director | Buy | 1,570.00 | 5,943.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031958/0001144204-19-031958-index.htm | ||
| 2020-01-07 | Jason Campagna | Chief Medical Officer | Sell | 732.00 | 113.02 | 82,730.64 | 6,303.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920002350/0001104659-20-002350-index.htm |
| 2019-06-20 | DANIEL G WELCH | Director | Buy | 1,570.00 | 6,465.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031952/0001144204-19-031952-index.htm | ||
| 2019-06-20 | GLENN SBLENDORIO | Director | Buy | 1,570.00 | 7,086.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031960/0001144204-19-031960-index.htm | ||
| 2019-06-20 | DANIEL BRADBURY | Director | Buy | 1,570.00 | 7,187.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031955/0001144204-19-031955-index.htm | ||
| 2019-06-20 | GINO SANTINI | Director | Buy | 1,570.00 | 7,284.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031959/0001144204-19-031959-index.htm | ||
| 2019-12-19 | Jason Campagna | Chief Medical Officer | Sell | 154.00 | 119.45 | 18,395.30 | 7,444.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465919075193/0001104659-19-075193-index.htm |
| 2020-05-28 | Nancy Miller-Rich | Director | Buy | 1,595.00 | 7,538.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068534/0001104659-20-068534-index.htm | ||
| 2019-05-14 | Luca Benatti | Director | Buy | 1,200.00 | 83.50 | 100,200.00 | 7,556.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419026103/0001144204-19-026103-index.htm |
| 2020-05-28 | DANIEL G WELCH | Director | Buy | 1,595.00 | 8,060.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068530/0001104659-20-068530-index.htm | ||
| 2019-06-20 | Keith Michael Gottesdiener | Director | Buy | 1,570.00 | 8,358.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031957/0001144204-19-031957-index.htm | ||
| 2020-05-28 | GLENN SBLENDORIO | Director | Buy | 1,595.00 | 8,681.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068531/0001104659-20-068531-index.htm | ||
| 2020-08-18 | Jason Campagna | Chief Medical Officer | Sell | 1,192.00 | 47.44 | 56,542.52 | 8,778.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920097335/0001104659-20-097335-index.htm |
| 2020-05-28 | DANIEL BRADBURY | Director | Buy | 1,595.00 | 8,782.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068536/0001104659-20-068536-index.htm | ||
| 2020-05-28 | GINO SANTINI | Director | Buy | 1,595.00 | 8,879.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068533/0001104659-20-068533-index.htm | ||
| 2019-06-20 | Luca Benatti | Director | Buy | 1,570.00 | 9,126.00 | https://www.sec.gov/Archives/edgar/data/1270073/000114420419031954/0001144204-19-031954-index.htm | ||
| 2020-05-28 | Keith Michael Gottesdiener | Director | Buy | 1,595.00 | 9,953.00 | https://www.sec.gov/Archives/edgar/data/1270073/000110465920068535/0001104659-20-068535-index.htm |